Durability of Response to Treatment among Antiretroviral‐Experienced Subjects: 48‐Week Results from AIDS Clinical Trials Group Protocol 359

Autor: Jon Cook, Charles B. Hicks, Bruce Coon, Richard Hutt, Margaret A. Fischl, David Pearson, Jan Clark, Candida T. Talabucon, Carol L. Brosgart, Joan Dragavon, Laura Ponticello, Janet Devine, Eugene Sun, Melissa Kerkau, Daniel C. Rodrigue, Donna Thee, Jeanne Berg, Mario Guerrero, Lyle Oshita, Jane L. Norris, Judy Aberg, Mark I. Becker, John Fuchs, Pablo Tebas, Guillermo J. Vázquez, Pamposh Kaul, Antoinette Kenton, Phyllis Barnett, Pascal J. de Caprariis, Michael Royal, Michelle Jack, Ann Walawander, Harold A. Kessler, Scott Souza, Sharon Shriver, Genice Hamilton, Susan E. Cohn, Hailong Cheng, John G. Gerber, Monica Millard, Sherree Wright, Linh Ngo, Gildon N. Beall, Debra Ogata-Arakaki, John Mc Neil, David M. Mushatt, Courtney V. Fletcher, Charles van der Horst, Karen Waterman, Ileana Lopez, David Katzenstein, Robert J. Fass, Joseph J. Eron, Edward P. Acosta, Stephen W. Lagakos, Hilda Mendoza, Jim Bruce, Michael F. Para, Sally Snyder, Mary Shoemaker, Mark A. Beilke, Tammy Powell, Margaret Nelson, Juan J.L. Lertora, Liliana Aguinada, Virginia Ramirez, M. Graham Ray, William W. Freimuth, Brenda Greenhill, Beverly Putnam, Aouie Carrera, Mary Albrecht, Michael F. Giordano, Stuart Carr, John M. Leedom, Charlotte Mills, Charles J. Gonzalez, Rebecca Becker, Richard Haubrich, Elizabeth Gimbel, D. Baker, Vivian Yuan, Andrea Weiss, Hongyu Jiang, Cheryl N. Karol, Kim Ingersol, Russell Strada, Paulette Mac Dougall, Carla Pettinelli, Glenna M. Auerback, Alice F. Mercado, Frances Canchola, Chris Helker, Susan A. Fiscus, X. Joan Hu, Janine R. Maenza, Henry S. Sacks, Robert Kalajian, Debbie Slamowitz, Robin Shepard, Margo Heath-Chiozzi, Michael J. Borucki, Ana Martinez, Olivia T. Ortiz, Suzanne Fiorillo, Jorge Santana, Michael S. Saag, Dena Duran, Steve Nowling, Jeff Taylor, Kristine Todd, Robert W. Coombs, Douglas D. Richman, Thomas C. Merigan, Robert Delapenha, Kenneth Wood, Harvey M. Friedman, Joseph Pulvirenti, Don Craven, Timothy W. Schacker, Ronald Swanstrom, Neel French, Judith Feinberg, Mark A. Jacobson, Judith Brown, Joseph Wheat, Ross G. Hewitt, James F. Rooney, Scott A. Smith, Bruce Peel, Doris Shank, Lisa Alexis, Roy M. Gulick, Andrea Christopher Belschner, Linda Meixner

Publikováno v: The Journal of Infectious Diseases. 186:626-633

The 24-week extension of AIDS Clinical Trials Group Protocol 359, a study of human immunodeficiency virus (HIV)‐infected, indinavir-experienced patients, was designed to study the durability of “salvage” treatment regimens. Patients received sa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca3b1c2613fffeb024856928c7b68a2
https://doi.org/10.1086/342681